Literature DB >> 15789560

Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery.

D S Samiulla1, V V Vaidyanathan, P C Arun, G Balan, M Blaze, S Bondre, G Chandrasekhar, A Gadakh, R Kumar, G Kharvi, H O Kim, S Kumar, J A Malikayil, M Moger, M K Mone, P Nagarjuna, C Ogbu, D Pendhalkar, A V S Raja Rao, G Venkateshwar Rao, V K Sarma, S Shaik, G V R Sharma, S Singh, C Sreedhar, R Sonawane, U Timmanna, L W Hardy.   

Abstract

Natural product analogs are significant sources for therapeutic agents. To capitalize efficiently on the effective features of naturally occurring substances, a natural product-based library production platform has been devised at Aurigene for drug lead discovery. This approach combines the attractive biological and physicochemical properties of natural product scaffolds, provided by eons of natural selection, with the chemical diversity available from parallel synthetic methods. Virtual property analysis, using computational methods described here, guides the selection of a set of natural product scaffolds that are both structurally diverse and likely to have favorable pharmacokinetic properties. The experimental characterization of several in vitro ADME properties of twenty of these scaffolds, and of a small set of designed congeners based upon one scaffold, is also described. These data confirm that most of the scaffolds and the designed library members have properties favorable to their utilization for creating libraries of lead-like molecules.

Mesh:

Substances:

Year:  2005        PMID: 15789560     DOI: 10.1007/s11030-005-1297-7

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  16 in total

Review 1.  Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.

Authors:  Z Yan; G W Caldwell
Journal:  Curr Top Med Chem       Date:  2001-11       Impact factor: 3.295

Review 2.  GUGULIPID: a natural cholesterol-lowering agent.

Authors:  Nancy L Urizar; David D Moore
Journal:  Annu Rev Nutr       Date:  2003-02-26       Impact factor: 11.848

Review 3.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

4.  Design and application of fluorometric assays for human cytochrome P450 inhibition.

Authors:  Charles L Crespi; Vaughn P Miller; David M Stresser
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

Review 5.  Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.

Authors:  T Iwatsubo; N Hirota; T Ooie; H Suzuki; N Shimada; K Chiba; T Ishizaki; C E Green; C A Tyson; Y Sugiyama
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

6.  Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.

Authors:  Miklos Feher; Jonathan M Schmidt
Journal:  J Chem Inf Comput Sci       Date:  2003 Jan-Feb

Review 7.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

Review 8.  ADME-Tox in drug discovery: integration of experimental and computational technologies.

Authors:  Hongshi Yu; Adedayo Adedoyin
Journal:  Drug Discov Today       Date:  2003-09-15       Impact factor: 7.851

9.  Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.

Authors:  Arun K Mandagere; Thomas N Thompson; Kin-Kai Hwang
Journal:  J Med Chem       Date:  2002-01-17       Impact factor: 7.446

10.  Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery.

Authors:  Chad L Stoner; Adriaan Cleton; Kjell Johnson; Doo-Man Oh; Hussein Hallak; Joanne Brodfuehrer; Narayanan Surendran; Hyo-Kyung Han
Journal:  Int J Pharm       Date:  2004-01-09       Impact factor: 5.875

View more
  4 in total

1.  Optimization of the antitumor activity of sequence-specific pyrrolobenzodiazepine derivatives based on their affinity for ABC transporters.

Authors:  Maciej Kaliszczak; Dyeison Antonow; Katan I Patel; Philip Howard; Duncan I Jodrell; David E Thurston; Sylvie M Guichard
Journal:  AAPS J       Date:  2010-08-12       Impact factor: 4.009

Review 2.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

Review 3.  Virtual screening for the discovery of bioactive natural products.

Authors:  Judith M Rollinger; Hermann Stuppner; Thierry Langer
Journal:  Prog Drug Res       Date:  2008

Review 4.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.